Olema Pharmaceuticals, Inc. (OLMA)
24.02
-0.18
(-0.74%)
USD |
NASDAQ |
Mar 02, 16:00
23.86
-0.16
(-0.67%)
Pre-Market: 08:08
Olema Pharmaceuticals Shareholders Equity (Quarterly) : 307.49M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Cogent Biosciences, Inc. | 636.37M |
| Corvus Pharmaceuticals, Inc. | 71.77M |
| Protagonist Therapeutics, Inc. | 614.71M |
| BridgeBio Pharma, Inc. | -2.087B |
| Oric Pharmaceuticals, Inc. | 384.36M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 352.45M |
| Total Liabilities (Quarterly) | 44.96M |
| Debt to Equity Ratio | 0.0146 |
| Current Ratio | 8.026 |
| Net Debt Paydown Yield | -0.07% |